Skip to main content
Tentative approval granted by FDA to Yabao's Nexavar biosimilar
7/15/2019

Yabao Pharmaceutical of China was granted tentative approval by the FDA for sorafenib tosylate, a biosimilar to Bayer's cancer drug Nexavar, or sorafenib.

Full Story: